CHINA China's first four-strain flu vaccine approved

CHINA

China's first four-strain flu vaccine approved

Xinhua

23:33, June 11, 2018

A child with flu receives treatment at Fujian Maternity and Child Healthcare Hospital in Fuzhou, Fujian province. [File Photo/Xinhua)

A child with flu receives treatment at Fujian Maternity and Child Healthcare Hospital in Fuzhou, Fujian Province. (Photo: Xinhua)

China's drug regulator has approved the country's first vaccine that can protect people from four influenza virus strains.

The four-strain vaccine adds protection against the Yamagata lineage of Influenza B, which was the main virus strain during the last flu season, according to the National Drug Administration of China.

Two domestic companies -- Hualan and Changsheng -- are the approved vaccine producers. The vaccine may be used on adults and children aged three years and above.

H1N1 and H3N2 of Influenza A, and Victoria and Yamagata lineages of Influenza B are the common strains of human flu viruses. Until now, China had only three-strain vaccines on the market.

The seasonal flu is an acute respiratory infection caused by influenza viruses, affecting seniors, infants, and people with cardiopulmonary diseases in particular. Vaccination is considered the most effective way to prevent infection and guard against an epidemic.

Last winter, northern China regions battled a surge of flu infections. Child cases reportedly rose sharply, leading to crowded hospitals.  

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue